 | • レポートコード：MRC2-11QY10867 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗てんかん薬のグローバル市場について調査・分析したレポートです。種類別（部分的、一般化）市場規模、用途別（小売薬局、病院薬局、ドラッグストア、オンライン）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗てんかん薬の競争状況、市場シェア ・世界の抗てんかん薬市場：種類別市場規模 2015年-2020年（部分的、一般化） ・世界の抗てんかん薬市場：種類別市場規模予測 2021年-2026年（部分的、一般化） ・世界の抗てんかん薬市場：用途別市場規模 2015年-2020年（小売薬局、病院薬局、ドラッグストア、オンライン） ・世界の抗てんかん薬市場：用途別市場規模予測 2021年-2026年（小売薬局、病院薬局、ドラッグストア、オンライン） ・北米の抗てんかん薬市場分析：米国、カナダ ・ヨーロッパの抗てんかん薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗てんかん薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗てんかん薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗てんかん薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Cephalon、Sunovion Pharmaceuticals、Valeant Pharmaceuticals International、Sanofi、UCB Pharma、GlaxoSmithKline、Johnson & Johnson、Novartis、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Antiepileptic Drugs Market
The global Antiepileptic Drugs market size is projected to reach US$ 4076.9 million by 2026, from US$ 3984.1 million in 2020, at a CAGR of 2.2%% during 2021-2026.
Global Antiepileptic Drugs Scope and Market Size
Antiepileptic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiepileptic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Cephalon
Sunovion Pharmaceuticals
Valeant Pharmaceuticals International
Sanofi
UCB Pharma
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
Market segment by Type, the product can be split into
Partial
Generalized
Market segment by Application, split into
Retail Pharmacies
Hospitals Pharmacies
Drug-store
Online
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antiepileptic Drugs Revenue
1.4 Market by Type
1.4.1 Global Antiepileptic Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Partial
1.4.3 Generalized
1.5 Market by Application
1.5.1 Global Antiepileptic Drugs Market Share by Application: 2020 VS 2026
1.5.2 Retail Pharmacies
1.5.3 Hospitals Pharmacies
1.5.4 Drug-store
1.5.5 Online
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Antiepileptic Drugs Market Perspective (2015-2026)
2.2 Global Antiepileptic Drugs Growth Trends by Regions
2.2.1 Antiepileptic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Antiepileptic Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Antiepileptic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Antiepileptic Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Antiepileptic Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Antiepileptic Drugs Players by Market Size
3.1.1 Global Top Antiepileptic Drugs Players by Revenue (2015-2020)
3.1.2 Global Antiepileptic Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Antiepileptic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antiepileptic Drugs Market Concentration Ratio
3.2.1 Global Antiepileptic Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Antiepileptic Drugs Revenue in 2019
3.3 Antiepileptic Drugs Key Players Head office and Area Served
3.4 Key Players Antiepileptic Drugs Product Solution and Service
3.5 Date of Enter into Antiepileptic Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antiepileptic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Antiepileptic Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Antiepileptic Drugs Market Size by Application (2015-2020)
5.2 Global Antiepileptic Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Antiepileptic Drugs Market Size (2015-2020)
6.2 Antiepileptic Drugs Key Players in North America (2019-2020)
6.3 North America Antiepileptic Drugs Market Size by Type (2015-2020)
6.4 North America Antiepileptic Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Antiepileptic Drugs Market Size (2015-2020)
7.2 Antiepileptic Drugs Key Players in Europe (2019-2020)
7.3 Europe Antiepileptic Drugs Market Size by Type (2015-2020)
7.4 Europe Antiepileptic Drugs Market Size by Application (2015-2020)
8 China
8.1 China Antiepileptic Drugs Market Size (2015-2020)
8.2 Antiepileptic Drugs Key Players in China (2019-2020)
8.3 China Antiepileptic Drugs Market Size by Type (2015-2020)
8.4 China Antiepileptic Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Antiepileptic Drugs Market Size (2015-2020)
9.2 Antiepileptic Drugs Key Players in Japan (2019-2020)
9.3 Japan Antiepileptic Drugs Market Size by Type (2015-2020)
9.4 Japan Antiepileptic Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Antiepileptic Drugs Market Size (2015-2020)
10.2 Antiepileptic Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antiepileptic Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Antiepileptic Drugs Market Size by Application (2015-2020)
11 India
11.1 India Antiepileptic Drugs Market Size (2015-2020)
11.2 Antiepileptic Drugs Key Players in India (2019-2020)
11.3 India Antiepileptic Drugs Market Size by Type (2015-2020)
11.4 India Antiepileptic Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Antiepileptic Drugs Market Size (2015-2020)
12.2 Antiepileptic Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Antiepileptic Drugs Market Size by Type (2015-2020)
12.4 Central & South America Antiepileptic Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Antiepileptic Drugs Introduction
13.1.4 Abbott Laboratories Revenue in Antiepileptic Drugs Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Cephalon
13.2.1 Cephalon Company Details
13.2.2 Cephalon Business Overview
13.2.3 Cephalon Antiepileptic Drugs Introduction
13.2.4 Cephalon Revenue in Antiepileptic Drugs Business (2015-2020)
13.2.5 Cephalon Recent Development
13.3 Sunovion Pharmaceuticals
13.3.1 Sunovion Pharmaceuticals Company Details
13.3.2 Sunovion Pharmaceuticals Business Overview
13.3.3 Sunovion Pharmaceuticals Antiepileptic Drugs Introduction
13.3.4 Sunovion Pharmaceuticals Revenue in Antiepileptic Drugs Business (2015-2020)
13.3.5 Sunovion Pharmaceuticals Recent Development
13.4 Valeant Pharmaceuticals International
13.4.1 Valeant Pharmaceuticals International Company Details
13.4.2 Valeant Pharmaceuticals International Business Overview
13.4.3 Valeant Pharmaceuticals International Antiepileptic Drugs Introduction
13.4.4 Valeant Pharmaceuticals International Revenue in Antiepileptic Drugs Business (2015-2020)
13.4.5 Valeant Pharmaceuticals International Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Antiepileptic Drugs Introduction
13.5.4 Sanofi Revenue in Antiepileptic Drugs Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 UCB Pharma
13.6.1 UCB Pharma Company Details
13.6.2 UCB Pharma Business Overview
13.6.3 UCB Pharma Antiepileptic Drugs Introduction
13.6.4 UCB Pharma Revenue in Antiepileptic Drugs Business (2015-2020)
13.6.5 UCB Pharma Recent Development
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Details
13.7.2 GlaxoSmithKline Business Overview
13.7.3 GlaxoSmithKline Antiepileptic Drugs Introduction
13.7.4 GlaxoSmithKline Revenue in Antiepileptic Drugs Business (2015-2020)
13.7.5 GlaxoSmithKline Recent Development
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Details
13.8.2 Johnson & Johnson Business Overview
13.8.3 Johnson & Johnson Antiepileptic Drugs Introduction
13.8.4 Johnson & Johnson Revenue in Antiepileptic Drugs Business (2015-2020)
13.8.5 Johnson & Johnson Recent Development
13.9 Novartis
13.9.1 Novartis Company Details
13.9.2 Novartis Business Overview
13.9.3 Novartis Antiepileptic Drugs Introduction
13.9.4 Novartis Revenue in Antiepileptic Drugs Business (2015-2020)
13.9.5 Novartis Recent Development
13.10 Pfizer
13.10.1 Pfizer Company Details
13.10.2 Pfizer Business Overview
13.10.3 Pfizer Antiepileptic Drugs Introduction
13.10.4 Pfizer Revenue in Antiepileptic Drugs Business (2015-2020)
13.10.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Antiepileptic Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Antiepileptic Drugs Revenue
Table 3. Ranking of Global Top Antiepileptic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antiepileptic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Partial
Table 6. Key Players of Generalized
Table 7. Global Antiepileptic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Antiepileptic Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Antiepileptic Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Antiepileptic Drugs Market Share by Regions (2015-2020)
Table 11. Global Antiepileptic Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Antiepileptic Drugs Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Antiepileptic Drugs Market Growth Strategy
Table 17. Main Points Interviewed from Key Antiepileptic Drugs Players
Table 18. Global Antiepileptic Drugs Revenue by Players (2015-2020) (Million US$)
Table 19. Global Antiepileptic Drugs Market Share by Players (2015-2020)
Table 20. Global Top Antiepileptic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiepileptic Drugs as of 2019)
Table 21. Global Antiepileptic Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Antiepileptic Drugs Product Solution and Service
Table 24. Date of Enter into Antiepileptic Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antiepileptic Drugs Market Size by Type (2015-2020) (Million US$)
Table 27. Global Antiepileptic Drugs Market Size Share by Type (2015-2020)
Table 28. Global Antiepileptic Drugs Revenue Market Share by Type (2021-2026)
Table 29. Global Antiepileptic Drugs Market Size Share by Application (2015-2020)
Table 30. Global Antiepileptic Drugs Market Size by Application (2015-2020) (Million US$)
Table 31. Global Antiepileptic Drugs Market Size Share by Application (2021-2026)
Table 32. North America Key Players Antiepileptic Drugs Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Antiepileptic Drugs Market Share (2019-2020)
Table 34. North America Antiepileptic Drugs Market Size by Type (2015-2020) (Million US$)
Table 35. North America Antiepileptic Drugs Market Share by Type (2015-2020)
Table 36. North America Antiepileptic Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. North America Antiepileptic Drugs Market Share by Application (2015-2020)
Table 38. Europe Key Players Antiepileptic Drugs Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Antiepileptic Drugs Market Share (2019-2020)
Table 40. Europe Antiepileptic Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Antiepileptic Drugs Market Share by Type (2015-2020)
Table 42. Europe Antiepileptic Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Antiepileptic Drugs Market Share by Application (2015-2020)
Table 44. China Key Players Antiepileptic Drugs Revenue (2019-2020) (Million US$)
Table 45. China Key Players Antiepileptic Drugs Market Share (2019-2020)
Table 46. China Antiepileptic Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. China Antiepileptic Drugs Market Share by Type (2015-2020)
Table 48. China Antiepileptic Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. China Antiepileptic Drugs Market Share by Application (2015-2020)
Table 50. Japan Key Players Antiepileptic Drugs Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Antiepileptic Drugs Market Share (2019-2020)
Table 52. Japan Antiepileptic Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Antiepileptic Drugs Market Share by Type (2015-2020)
Table 54. Japan Antiepileptic Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Antiepileptic Drugs Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Antiepileptic Drugs Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Antiepileptic Drugs Market Share (2019-2020)
Table 58. Southeast Asia Antiepileptic Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Antiepileptic Drugs Market Share by Type (2015-2020)
Table 60. Southeast Asia Antiepileptic Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Antiepileptic Drugs Market Share by Application (2015-2020)
Table 62. India Key Players Antiepileptic Drugs Revenue (2019-2020) (Million US$)
Table 63. India Key Players Antiepileptic Drugs Market Share (2019-2020)
Table 64. India Antiepileptic Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. India Antiepileptic Drugs Market Share by Type (2015-2020)
Table 66. India Antiepileptic Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. India Antiepileptic Drugs Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Antiepileptic Drugs Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Antiepileptic Drugs Market Share (2019-2020)
Table 70. Central & South America Antiepileptic Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Antiepileptic Drugs Market Share by Type (2015-2020)
Table 72. Central & South America Antiepileptic Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Antiepileptic Drugs Market Share by Application (2015-2020)
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Product
Table 77. Abbott Laboratories Revenue in Antiepileptic Drugs Business (2015-2020) (Million US$)
Table 78. Abbott Laboratories Recent Development
Table 79. Cephalon Company Details
Table 80. Cephalon Business Overview
Table 81. Cephalon Product
Table 82. Cephalon Revenue in Antiepileptic Drugs Business (2015-2020) (Million US$)
Table 83. Cephalon Recent Development
Table 84. Sunovion Pharmaceuticals Company Details
Table 85. Sunovion Pharmaceuticals Business Overview
Table 86. Sunovion Pharmaceuticals Product
Table 87. Sunovion Pharmaceuticals Revenue in Antiepileptic Drugs Business (2015-2020) (Million US$)
Table 88. Sunovion Pharmaceuticals Recent Development
Table 89. Valeant Pharmaceuticals International Company Details
Table 90. Valeant Pharmaceuticals International Business Overview
Table 91. Valeant Pharmaceuticals International Product
Table 92. Valeant Pharmaceuticals International Revenue in Antiepileptic Drugs Business (2015-2020) (Million US$)
Table 93. Valeant Pharmaceuticals International Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Antiepileptic Drugs Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. UCB Pharma Company Details
Table 100. UCB Pharma Business Overview
Table 101. UCB Pharma Product
Table 102. UCB Pharma Revenue in Antiepileptic Drugs Business (2015-2020) (Million US$)
Table 103. UCB Pharma Recent Development
Table 104. GlaxoSmithKline Company Details
Table 105. GlaxoSmithKline Business Overview
Table 106. GlaxoSmithKline Product
Table 107. GlaxoSmithKline Revenue in Antiepileptic Drugs Business (2015-2020) (Million US$)
Table 108. GlaxoSmithKline Recent Development
Table 109. Johnson & Johnson Business Overview
Table 110. Johnson & Johnson Product
Table 111. Johnson & Johnson Company Details
Table 112. Johnson & Johnson Revenue in Antiepileptic Drugs Business (2015-2020) (Million US$)
Table 113. Johnson & Johnson Recent Development
Table 114. Novartis Company Details
Table 115. Novartis Business Overview
Table 116. Novartis Product
Table 117. Novartis Revenue in Antiepileptic Drugs Business (2015-2020) (Million US$)
Table 118. Novartis Recent Development
Table 119. Pfizer Company Details
Table 120. Pfizer Business Overview
Table 121. Pfizer Product
Table 122. Pfizer Revenue in Antiepileptic Drugs Business (2015-2020) (Million US$)
Table 123. Pfizer Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiepileptic Drugs Market Share by Type: 2020 VS 2026
Figure 2. Partial Features
Figure 3. Generalized Features
Figure 4. Global Antiepileptic Drugs Market Share by Application: 2020 VS 2026
Figure 5. Retail Pharmacies Case Studies
Figure 6. Hospitals Pharmacies Case Studies
Figure 7. Drug-store Case Studies
Figure 8. Online Case Studies
Figure 9. Antiepileptic Drugs Report Years Considered
Figure 10. Global Antiepileptic Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Antiepileptic Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Antiepileptic Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Antiepileptic Drugs Market Share by Players in 2019
Figure 15. Global Top Antiepileptic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiepileptic Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Antiepileptic Drugs Revenue in 2019
Figure 17. North America Antiepileptic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Antiepileptic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Antiepileptic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Antiepileptic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Antiepileptic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Antiepileptic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Antiepileptic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
植物・植物由来薬剤の世界市場（～2026年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
- OTC外用薬の世界市場（～2026年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…
- 眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…
- 神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…